SPRY

SPRY Deferred Revenue

$535.00KQuarterly · USD

Period ending:

SPRY FY Deferred RevenueUSD
SPRY FY Deferred Revenue2018-12-31: $0.002019-12-31: $0.002020-12-31: $3.52M2021-12-31: $1.46M2022-12-31: $0.002023-12-31: $0.002024-12-31: $557.00K2025-12-31: $609.00K$3.52M$0.00
2018-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

SPRY deferred revenue history

Revenue received but not yet earned. The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.

Ars Pharmaceuticals Inc Deferred Revenue — Annual fiscal periods (USD)
Period endingDeferred Revenue (USD)
609,000
557,000
0
0
1,457,000
3,518,000
0
0

Compare deferred revenue

All SPRY financial metrics · SPRY stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.